Utility of Presepsin in Distinguishing Between Sepsis and SIRS
NCT02052895 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 226
Last updated 2018-08-21
Summary
This is an observational study to evaluate the diagnostic accuracy of presepsin levels to discriminate between sepsis and SIRS upon presentation with critical illness compatible with either sepsis or systemic inflammatory response syndrome (SIRS).
Conditions
- SIRS
- Sepsis
Sponsors & Collaborators
-
Mochida Pharmaceutical Company, Ltd.
lead INDUSTRY
Principal Investigators
-
Stanley Nasraway, MD, FCCM · Tufts Medical Center
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2015-07-31
- Completion
- 2015-07-31
Countries
- United States
Study Locations
More Related Trials
-
Early PREdiction of Severe Sepsis I (ExPRES-Sepsis I) Study
NCT02188992 ·Status: COMPLETED
-
The Application of SERS and Metabolomics in Sepsis
NCT02213237 ·Status: UNKNOWN
-
Early Identification of Sepsis in Children
NCT03884595 ·Status: UNKNOWN
-
A Prospective Observational Study of Sepsis
NCT05309889 ·Status: UNKNOWN
-
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584 ·Status: UNKNOWN
-
Application of Biomarkers Change to Predict Outcome of Patient With Severe Sepsis
NCT02871895 ·Status: UNKNOWN
-
The Role of Myristic Acid in Serum for Early Diagnosis of Sepsis and Comparison With Selected Biomarkers of Sepsis
NCT03314831 ·Status: COMPLETED
-
A Blood Test to Diagnose Sepsis in Symptomatic Adults and Children
NCT05142813 ·Status: UNKNOWN
-
Serum Procalcitonin
NCT00954551 ·Status: COMPLETED
-
Early Diagnosis and Prognosis of Postoperative Sepsis by Presepsin and Syndecan-1
NCT04718623 ·Status: UNKNOWN
-
Novel Sepsis Sub-phenotypes Based on Trajectories of Vital Signs
NCT05826223 ·Status: COMPLETED
-
The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis
NCT03340649 ·Status: UNKNOWN
-
Does Serum Procalcitonin Levels Predict Sepsis in Patients Undergoing Cytoreductive Surgery
NCT02189434 ·Status: COMPLETED
-
Outcome Predictors in Patients With Severe Sepsis and Optimized Central Venous Oxygen Saturation
NCT01362829 ·Status: COMPLETED
-
Effect of APC and Epo on the Inflammatory Response During Sepsis
NCT00229034 ·Status: COMPLETED
-
Application of Stimulated Immune Response Change to Predict Outcome of Patient With Severe Sepsis
NCT02887274 ·Status: UNKNOWN
-
Presepsin Diagnostic Performance in Severe Burn Sepsis
NCT07060560 ·Status: RECRUITING
-
Combined Determination of sTREM-1, PCT and CD64 in Diagnosing Sepsis
NCT02198950 ·Status: COMPLETED
-
Comparison of Sepsis Prediction Algorithms
NCT05943938 ·Status: NOT_YET_RECRUITING
-
Preemptive Resuscitation for Eradication of Septic Shock
NCT01449721 ·Status: COMPLETED ·Phase: NA
-
Sensitivity and Specificity of Leucocytes Profiling Versus Platelet Indices in Prediction of Clinical Outcome for Candidates With Sepsis. A Bi-centric Observational Clinical Trial
NCT06612307 ·Status: COMPLETED
-
Plasma Inducible Nitric Oxide Synthase (iNOS) Assay and Sepsis Study
NCT01371929 ·Status: TERMINATED
-
Early Vasopressors in Sepsis
NCT05179499 ·Status: RECRUITING ·Phase: PHASE3
-
Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis
NCT01746407 ·Status: COMPLETED
-
STUDY00015328: Sepsis Endotypes
NCT03146546 ·Status: ENROLLING_BY_INVITATION